XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $559 | +7.1% | 14,515 | -0.6% | 0.02% | 0.0% |
| Q1 2023 | $522 | -9.7% | 14,598 | -0.3% | 0.02% | -12.0% |
| Q4 2022 | $578 | -99.9% | 14,649 | -15.8% | 0.02% | +4.2% |
| Q3 2022 | $628,000 | -6.3% | 17,400 | -21.0% | 0.02% | +20.0% |
| Q2 2022 | $670,000 | -0.4% | 22,025 | -0.0% | 0.02% | +25.0% |
| Q1 2022 | $673,000 | -14.9% | 22,031 | -13.0% | 0.02% | 0.0% |
| Q4 2021 | $791,000 | +105.5% | 25,329 | +0.7% | 0.02% | +77.8% |
| Q3 2021 | $385,000 | -21.3% | 25,165 | -4.1% | 0.01% | 0.0% |
| Q2 2021 | $489,000 | +10.1% | 26,245 | +5.8% | 0.01% | 0.0% |
| Q1 2021 | $444,000 | – | 24,805 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |